Convatec announced that it received FDA approval for the delivery of a Parkinson's disease therapy through its Neria Guard ...

Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

Glucotrack today announced the results from the first-in-human clinical study of its long-term continuous blood glucose ...

“Inhaled insulin can quickly get to the carbohydrates that are in the bloodstream, get them into the cells and out of the ...